6 completed, 1 recruiting, 1 unknown. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers PanChol - Cholera Vaccination Reaction | Phase 1 | Recruiting | Centre for Infectious Disease Research in Zambia | 32 | 2026-05-20 | 2026-10-06 |
| First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers PanChol - Cholera, Cholera Vaccine Toxicity | Phase 1 | Unknown | Brigham and Women's Hospital | 53 | 2022-12-12 | 2022-12-20 |
| Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine HL-OCV, Shanchol - Cholera | Phase 1 / Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 840 | 2016-07-01 | 2018-11-02 |
| PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera iOWH032 - Diarrhea, Cholera | Phase 1 | Completed | PATH | 26 | 2013-05-01 | 2015-06-11 |
| To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men Euvichol - Prevention Harmful Effects | Phase 1 | Completed | EuBiologics Co.,Ltd | 20 | 2012-09-01 | 2013-02-20 |
| Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 PXVX0200, Placebo - Cholera | Phase 1 | Completed | Bavarian Nordic | 66 | 2012-04-01 | 2023-06-27 |
| Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects Ciprofloxacin, Peru-15-pCTB, Sodium bicarbonate/Ascorbic Acid/Aspartame Buffer - Gastroenteritis Escherichia Coli | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 62 | 2008-06-02 | 2021-07-29 |
| Studies of Immune Responses to Orally Administered Vaccines in Developing Country Placebo, Control, Zinc Sulphate - Cholera, Typhoid | Phase 1 / Phase 2 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 1016 | 2008-02-01 | 2011-07-12 |
Diarrhea (2) · Escherichia coli Infections (1) · Typhoid Fever (1)
Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Gram-Negative Bacterial Infections (8) · Infections (8) · Vibrio Infections (8) · Enterobacteriaceae Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Salmonella Infections (1)
Albendazole (1) · Arsenic (1) · Ciprofloxacin (1) · IOWH-032 (1) · Sodium Bicarbonate (1) · Zinc Sulfate (1) · secnidazole (1) · shanchol (1)
International Centre for Diarrhoeal Disease Research, Bangladesh (2) · Bavarian Nordic (1) · Brigham and Women's Hospital (1) · Centre for Infectious Disease Research in Zambia (1) · EuBiologics Co.,Ltd (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · PATH (1)
Bangladesh (3) · United States (3) · South Korea (1) · Zambia (1)
Firdausi Qadri, Dr. (1) · Firdausi Qadri, PhD (1) · Hong J Hee, Ph.D (1) · Mohammed A Salam, MBBS (1)
PMID 16760521, PMID 18398491, PMID 22461716, PMID 24173028, PMID 24753695, PMID 25410205, PMID 34218960, PMID 41519137